phase ib/ii multi-arm study of combinations of novel agents in r/r aml
Published 3 years ago • 27 plays • Length 4:45Download video MP4
Download video MP3
Similar videos
-
2:10
phase ib trial of entinostat in combination with pembrolizumab in r/r mds or aml
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:05:36
hematology tutorial for r2 internal medicine — part 2
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
4:54
beakertv | meet brenda montgomery, msl at biomea fusion
-
2:18
phase i/ii tg01 study exploring the use of vaccination in ras-mutated myeloma
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
2:41
a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:48
trials of interest in newly diagnosed myeloma presented at ims 2024
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
2:18
multi-dimensional analysis of the mutational landscape of aml
-
3:10
results of phase ii trial of olutasidenib in patients with r/r midh1 aml
-
4:22
the role of mrd in aml
-
2:58
long-term follow-up: phase ii study of apr-246 aza in tp53-mutated mds & aml
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv